FeaturesSignalPricingFounders
Log inGet started free
J&

Johnson & Johnson Innovation вАУ JJDC

Corporate VCActive

JJDC finds transformative ideas and helps them mature into real solutions for todayвАЩs patients.

Cambridge, United StatesFounded 2018jnjinnovation.com/jjdc
34
Investments
10
Exits
—
AUM
29.4%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Johnson & Johnson Innovation вАУ JJDC.

Get started free

Investment Thesis & Strategy

JJDC, as a corporate venture capital arm, invests in various stages across a broad range of industries, seeking transformative ideas that can mature into impactful solutions for patients.

Investment Activity

Deals per year over the last 12 years

1
2008
2
2009
0
2010
4
2011
1
2012
1
2013
0
2014
1
2015
1
2016
0
2017
0
2018
1
2019

Portfolio Companies

Selected investments from their portfolio of 34 companies

C
Cellarity
Biotech · Series A, 2019
Active
L
Lyndra Therapeutics
Biotech · Series B, 2016
Active
S
Surface Oncology
Biotech · Series A, 2015
Active
C
Catabasis Pharmaceuticals
Biotech · Series B, 2013
Active
T
Theravance Biopharma
Biotech · Series B, 2012
Active
A
Ariad Pharmaceuticals
Biotech · Series C+, 2011
Active
N
Novira Therapeutics
Biotech · Series A, 2011
Active
E
Epizyme
Biotech · Series B, 2011
Active
I
Intercept Pharmaceuticals
Biotech · Series B, 2011
Active
S
Sequenom
Biotech · Series B, 2009
Active
A
Adnexus Therapeutics
Biotech · Series A, 2009
Active
C
Cougar Biotechnology
Biotech · Series A, 2008
Active

Notable Exits

CompanyTypeYearValue / Acquirer
Aurion BiotechAcquisition2024—
ProteologixAcquisition2024—
Kiadis PharmaAcquisition2021$430M
Momenta PharmaceuticalsAcquisition2020$6.5B
Celltrion HealthcareIPO2018—
Adverum BiotechnologiesIPO2016—
Novira TherapeuticsAcquisition2015—
Alios BioPharmaAcquisition2014$1.75B
Aragon PharmaceuticalsAcquisition2013$1B
Cougar BiotechnologyAcquisition2009$970M

Frequently Asked Questions

Johnson & Johnson Innovation вАУ JJDC focuses on Series A, Series B stage investments.

Related Investors

SR One

Cambridge, United States · 144 deals

Sanofi Ventures

Cambridge, United States · 37 deals

Johnson & Johnson Innovation – JJDC

Cambridge, United States · 34 deals

Baxalta Ventures

Cambridge, United States · 6 deals

Partners HealthCare Innovation

Cambridge, United States · 1 deals

Brand Capital

Mumbai, India · 570 deals